FRANKFURT, Jan 22 (Reuters) - AstraZeneca has informed the European Commission that it will initially not be able to deliver the agreed volumes of its COVID-19 vaccine when it obtains regulatory approval for the bloc, which is expected by end-January, German newspaper Bild reported on Friday, citing company sources.
An AstraZeneca spokesman did not have an immediate comment when contacted by Reuters. (Reporting by Ludwig Burger; editing by Thomas Seythal)
Our Standards: The Thomson Reuters Trust Principles.